190 related articles for article (PubMed ID: 24447133)
1. Coronary artery bypass grafting versus drug-eluting stents in patients with end-stage renal disease.
Deo SV; Shah IK; Dunlay SM; Lim JY; Erwin PJ; Dillon JJ; Park SJ
J Card Surg; 2014 Mar; 29(2):163-9. PubMed ID: 24447133
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
[TBL] [Abstract][Full Text] [Related]
3. Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients.
Terazawa S; Tajima K; Takami Y; Tanaka K; Okada N; Usui A; Ueda Y
J Card Surg; 2012 May; 27(3):281-7. PubMed ID: 22500723
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
De Luca G; Schaffer A; Verdoia M; Suryapranata H
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
[TBL] [Abstract][Full Text] [Related]
5. PCI versus CABG for multivessel coronary disease in diabetics.
Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of drug-eluting stent implantation versus coronary artery bypass grafting for patients with coronary artery disease and chronic left ventricular systolic dysfunction.
Yang JH; Choi SH; Song YB; Hahn JY; Choi JH; Jeong DS; Sung K; Kim WS; Lee YT; Gwon HC
Am J Cardiol; 2013 Sep; 112(5):623-9. PubMed ID: 23711811
[TBL] [Abstract][Full Text] [Related]
7. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry.
Rodriguez AE; Maree AO; Mieres J; Berrocal D; Grinfeld L; Fernandez-Pereira C; Curotto V; Rodriguez-Granillo A; O'Neill W; Palacios IF
Eur Heart J; 2007 Sep; 28(17):2118-25. PubMed ID: 17656352
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
9. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
[TBL] [Abstract][Full Text] [Related]
10. Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials.
Mina GS; Watti H; Soliman D; Shewale A; Atkins J; Reddy P; Dominic P
Cardiovasc Revasc Med; 2018 Sep; 19(6):671-678. PubMed ID: 29396239
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
[TBL] [Abstract][Full Text] [Related]
12. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents versus coronary-artery bypass grafting.
Wu X; Chen Y; Liu H; Teirstein PS; Kirtane AJ; Ge C; Song X; Chen X; Gu C; Huang F; Lv S
Am J Cardiol; 2010 Jun; 105(12):1728-34. PubMed ID: 20538122
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
14. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.
Benedetto U; Melina G; Angeloni E; Refice S; Roscitano A; Fiorani B; Di Nucci GD; Sinatra R
Eur J Cardiothorac Surg; 2009 Oct; 36(4):611-5. PubMed ID: 19394857
[TBL] [Abstract][Full Text] [Related]
15. Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.
Li X; Kong M; Jiang D; Dong A
Interact Cardiovasc Thorac Surg; 2014 Mar; 18(3):347-54. PubMed ID: 24345688
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of effectiveness of first-generation drug-eluting stents versus coronary artery bypass grafting for unprotected left main coronary disease.
Jiang WB; Zhao W; Huang H; Li CL; Zhang JH; Wang Y; Fu GS
Am J Cardiol; 2012 Dec; 110(12):1764-72. PubMed ID: 23078911
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age.
Hannan EL; Zhong Y; Berger PB; Walford G; Curtis JP; Wu C; Venditti FJ; Higgins RS; Smith CR; Lahey SJ; King SB
Am J Cardiol; 2014 Mar; 113(5):803-8. PubMed ID: 24440331
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
19. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.
Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE
Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782
[TBL] [Abstract][Full Text] [Related]
20. Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).
Frutkin AD; Lindsey JB; Mehta SK; House JA; Spertus JA; Cohen DJ; Rumsfeld JS; Marso SP;
JACC Cardiovasc Interv; 2009 Jul; 2(7):614-21. PubMed ID: 19628183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
